We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hydrogel Dressings Improve Burn Care

By HospiMedica staff writers
Posted on 14 Feb 2006
A hydrogel-based burn dressing offers quick pain relief and reduces eventual scarring, according to a recent study. More...


BurnShield, manufactured by Levtrade (Germiston, South Africa), is a burn dressing made of a transparent adhesive with selective permeability, containing a hydrogel with an active ingredient called Melaleuca alternifolia, also known as tea tree oil. The burn dressing absorbs and dissipates heat, providing relief, minimizing shock and skin damage, halting the burn process, and physically protecting against further contamination.

In a study published in the January 2006 issue of the Archives of Surgery, BurnShield was applied to cutaneous burns, ranging from first- to third-degree in severity, in all patients as a first treatment. The film was reapplied every 24-48 hours until re-epithelialization occurred, which happened in a mean of 17 days. In cases of skin maceration, a condition that develops when skin is consistently wet until it softens, turns white, and can easily get infected with bacteria or fungi, wound care was switched to a conventional gauze with a hyaluronate sodium dressing.

Of the 44 patients in the study, 19 received one hydrogel application, eight received two applications, five received three, six received four, and the remainder of patients received between five and 15 applications. The mean duration of hydrogel applications in all patients was 94.4 days. Mean time to pain relief after the hydrogel application was 2.3 minutes.

In the two-year follow-up study, hypertrophic scars developed in 5% of patients. The author of the study, Dr. Enzo Osti, of the San Dona di Piave Hospital (Venice, Italy), pointed out that the literature indicates that such scarring typically occurs in 45-70% of burn cases, and attributes the significant reduction in scarring to a reduction in burn zone temperature by hydrogel application and a reduction in wound maceration.



Related Links:
Levtrade

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.